New technology for early detection of type 1 diabetes

July 10, 2018, RMIT University
The proof-of-concept sensor for the early detection of type 1 diabetes. Coated with special nanoparticles, the sensor can detect biomarkers in the blood that predict the health of insulin-producing cells. Credit: RMIT University

Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.

There is currently no early test for Type 1 diabetes and by the time someone is diagnosed, about 70 per cent of their critical insulin-producing cells have been destroyed.

The Australian researchers from RMIT University and University of Sydney hope their detection kit could one day be used as a standard test for newborns, catching the disease in its earliest stages and enabling the development of treatments to delay or even prevent its onset.

Professor Vipul Bansal, Director of the Ian Potter NanoBioSensing Facility at RMIT, said the collaboration combined lab-on-a-chip technologies with a breakthrough discovery on .

"The we're developing is cost-effective and simple to use, requiring no specialist technical knowledge or expensive analysis," Bansal said.

"Being able to detect this disease well before it has a chance to progress would be life-changing for the 2400 Australians diagnosed with Type 1 diabetes each year."

Type 1 diabetes is a lifelong autoimmune disorder that affects about 542,000 children around the world, with increasing numbers of adults also being diagnosed.

Credit: RMIT University

The technology being developed by RMIT scientists and engineers uses a microchip and sensor to detect markers in the blood that can identify the early loss of beta cells.

Beta cells are found in the pancreas and are the body's only way of making insulin, the sugar-regulating hormone that people with Type 1 diabetes cannot produce.

Researchers at the University of Sydney, led by Associate Professor Anand Hardikar, have previously discovered about 20 biomarkers in the blood that can accurately predict the health of .

The collaboration with RMIT builds on that breakthrough, with the aim of developing a point-of-care device to test for these biomarkers and produce results within minutes.

Led by Bansal and cell biologist Dr. Ravi Shukla, scientists at RMIT's Ian Potter NanoBiosensing Facility have already developed a proof-of-concept sensor coated with special nanoparticles. The sensor can reliably detect the presence of select biomarkers, changing colour if a particular molecule is present in the blood.

The next stage is working with the engineers at RMIT's Micro Nano Research Facility to expand the sensor's capabilities and miniaturise it onto a microfluidic chip about the size of a postage stamp.

A contains tiny channels and pumps that can precisely control fluid. While blood is notoriously difficult to handle in microfluidic systems, RMIT researchers have pioneered technology that avoids the need for special processing.

RMIT University's Professor Vipul Bansal with the proof-of-concept diabetes sensor. Credit: RMIT University

Micro Nano Research Facility Director, Professor Arnan Mitchell, said the final result would be a simple and reliable tool for health professionals.

"The prototype we're building will be able to analyse just a pin-prick of blood from a patient and provide a score that indicates the risk of Type 1 ," Mitchell said.

"The ultimate aim is to be able to slow or prevent the onset of Type 1 Diabetes. The test could also significantly boost the development of therapies to prevent or delay the disease.

"We know the separate components of the device work, so now the challenge is to bring the sensor and the chip together into one easy-to-use device."

The research is supported through over $AU1.2 million in funding from The Leona M and Harry B Helmsley Charitable Trust, one of the largest medical research-funding philanthropic trusts in the world.

The funding grant is administered by JDRF Australia, the nation's the peak body supporting research into Type 1 Diabetes.

Explore further: New hope from the 'seven year switch' in type 1 diabetes

Related Stories

New hope from the 'seven year switch' in type 1 diabetes

June 8, 2018
New research has shown that the rapid decline in insulin production that causes Type 1 diabetes continues to fall over seven years and then stabilises.

Researchers developing portable device for early diabetes detection

January 11, 2017
Researchers at the University of Twente, in cooperation with commercial parties, are developing a portable device for detecting type 1 or type 2 diabetes at an early stage. The STW Technology Foundation is funding a research ...

The relevance of GABA for diabetes highlighted in two new studies

April 5, 2018
Dynamic interactions between the nervous system, hormones and the immune system are normally ongoing, but in diabetes the balance is disturbed. Two studies published in EBioMedicine by an international research team from ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Insulin pill may delay type 1 diabetes in some

November 21, 2017
(HealthDay)—It's often said that timing is everything. New research suggests this may be true when giving an insulin pill to try to prevent or delay type 1 diabetes.

Recommended for you

High gluten diet in pregnancy linked to increased risk of diabetes in children

September 19, 2018
A high gluten intake by mothers during pregnancy is associated with an increased risk of their child developing type 1 diabetes, suggests a study published by The BMJ today.

Anti-inflammatory protein promotes healthy gut bacteria to curb obesity

September 19, 2018
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported ...

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity

September 11, 2018
Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.